Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β

Biochemistry

Volumn 43, Issue 2, 2004, Pages 560-568

  Atwood, Craig S ^a,b,e   Perry, George ^a   Zeng, Hong ^a   Kato, Yoji ^c   Jones, Walton D ^a   Ling, Ke Qing ^a   Huang, Xudong ^d   Moir, Robert D ^d   Wang, Dandan ^a   Sayre, Lawrence M ^a   Smith, Mark A ^a   Chen, Shu G ^a   Bush, Ashley I ^d,f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b EDITH COWAN UNIVERSITY   (Australia)

^c UNIVERSITY OF HYOGO   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; COPPER; CROSSLINKING; FLUORESCENCE; OLIGOMERS; OXIDATION;

OLIGOMERIZATION;

BIOCHEMISTRY;

AMYLOID BETA PROTEIN; COPPER; DODECYL SULFATE SODIUM; HYDROGEN PEROXIDE; OLIGOMER; TYROSINE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; COVALENT BOND; CROSS LINKING; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE; OLIGOMERIZATION; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; COPPER; CROSS-LINKING REAGENTS; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; SODIUM DODECYL SULFATE; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TYROSINE;

EID: 9144235443     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0358824     Document Type: Article

References (63)

1. Atwood, C. S., Moir, R. D., Huang, X., Bacarra, N. M. E., Scarpa, R. C., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998) Dramatic aggregation of Alzheimer Abeta by Cu(II) is induced by conditions representing physiological acidosis, J. Biol. Chem. 273, 12817-12826.
2. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (2000) Characterization of copper interactions with Alzheimer Aβ peptides: Identification of a attomolar affinity copper binding site on Aβ1-42, J. Neurochem. 75, 1219-1233.
3. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999) The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38, 7609-7616.
4. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J., Hanson, G. R., Stokes, K. C., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999) Alzheimer Aβ interaction with Cu(II) induces neurotoxicity, radicalization, metal reduction and hydrogen peroxide formation, J. Biol. Chem. 274, 37111-37116.
5. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun. 120, 885-890.
6. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
7. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism, Nature 359, 322-325.
8. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids, Nature 359, 325-327.
9. Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., and Younkin, S. G. (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing, Science 258, 126-129.
10. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem. 271, 4077-4081.
11. Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S., and Emmerling, M. R. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease, J. Biol. Chem. 271, 20631-20635.
12. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/ beta amyloid peptide analogs, J. Biol. Chem. 267, 546-554.
13. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., and Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease, J. Mol. Biol. 218, 149-163.
14. Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation, J. Biol. Chem. 267, 18210-18217.
15. Dyrks, T., Dyrks, E., Masters, C. L., and Beyreuther, K. (1993) Amyloidogenicity of rodent and human betaA4 sequences, FEBS Lett. 324, 231-236.
16. Bush, A. I., Pettingell, W. H., Jr., Paradis, M. D., and Tanzi, R. E. (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc, J. Biol. Chem. 269, 12152-12158.
17. Bush, A. I., Pettingell, W. H., Multhaup, G., de Paradis, M., Vonsattel, J. P. G. J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc, Science 265, 1464-1467.
18. Huang, X., Atwood, C. S., Moir, R. D., Hartshorn, M. A., Vonsattel, J.-P., Tanzi, R. E., and Bush, A. I. (1997) Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors, J. Biol. Chem. 272, 26464-26470.
19. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques, J. Neurol. Sci. 158, 47-52.
20. Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Perry, G., Smith, M. A., and Carey, P. R. (2003) Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence, Biochemistry 42, 2768-2773.
21. Atwood, C. S., Huang, X., Katri, A., Scarpa, R. C., Moir, R. D., Kim, Y.-S., Tanzi, R. E., Roher, A. E., and Bush, A. I. (2000) Copper catalyzed oxidation of Alzheimer Aβ, Cell. Mol. Biol. 46, 777-783.
22. Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., and Barnham, K. J. (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J. Biol. Chem. 276, 20466-20473.
23. Shen, H.-R., Spikes, J. D., Smith, C. J., and Kopecek, J. (2000) Photodynamic crosslinking of proteins V. Nature of the tyrosine-tyrosine bonds formed in the FMN-sensitized intermolecular crosslinking of N-acetyl-L-tyrosine, J. Photochem. Photobiol., A 133, 115-122.
24. Eickhoff, H., Jung, G., and Rieker, A. (2001) Oxidative phenol coupling: tyrosine dimers and libraries containing tyrosyl peptide dimers, Tetrahedron 57, 353-364.
25. Guo, Z.-W., Salamonczyk, G. M., Han, K., Machiya, K., and Sih, C. J. (1997) Enzymatic oxidative phenolic coupling, J. Org. Chem. 62, 6700-6701.
26. Nishiyama, S., Kim, M. H., and Yamamura, S. (1994) Syntheses of isodityrosine, dityrosine and related compounds by phenolic oxidation of tyrosine and phenylglycine derivatives using an electrochemical method, Tetrahedron Lett. 35, 8397-8400.
27. Kato, Y., Wu, X., Naito, M., Nomura, H., Kitamoto, N., and Osawa, T. (2000) Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody, Biochem. Biophys. Res. Commun. 275, 11-15.
28. Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., and Schenk, D. B. (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid, J. Neurochem. 61, 1965-1968.
29. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325, 733-736.
30. Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., and lqbal, K. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem. Biophys. 301, 41-52.
31. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 90, 10836-10840.
32. Shivers, B. D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K., and Seeburg, P. H. (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact, EMBO J. 7, 1365-1370.
33. Kato, Y., Kitamoto, N., Kawai, Y., and Osawa, T. (2001) The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine, Free Radical Biol. Med. 31, 624-632.
34. Kushioka, K., Tanimoto, I., and Maruyama, K. (1989) Oxidation of 2,4-di-tert-butylphenol by hydrogen peroxide catalyzed by bis-(ethylenediamine)copper(II) complexes, Bull. Chem. Soc. Jpn. 62, 1147-1153.
35. Smith, M. A., Harris, P. L. R., Sayre, L. M., and Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868.
36. Johnstone, E. M., Chaney, M. O., Norris, F. H., Pascual, R., and Little, S. P. (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis, Brain Res. Mol. Brain Res. 10, 299-305.
37. Giulian, D., Haverkamp, L. J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., and Roher, A. E. (1998) The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease, J. Biol. Chem. 273, 29719-29726.
38. Shinobu, L. A., and Beal, M. F. (1997) The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer's Disease, in Metals and Oxidative Damage in Neurological Disorders (Connor, J. R., Ed.) pp 237-275, Plenum Press, New York.
39. Hirai, K., Aliev, G., Nunomura, A., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., Cash, A., Siedlak, S. L., Jones, P. K., Petersen, R. B., Perry, G., and Smith, M. A. (2001) Mitochondrial DNA turnover is decreased in oxidatively stressed pyramidal neurons of the Alzheimer's disease brain, J. Neurosci. 21, 3017-3023.
40. Miura, T., Suzuki, K., Kohata, N., and Takeuchi, H. (2000) Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes, Biochemistry 39, 7024-7031.
41. Higgins, T. G., Wells-Knecht, M. C., Detorie, N. A., Baynes, J. W., and Thorpe, S. R. (1993) Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation, J. Biol. Chem. 268, 12341-12347.
42. Frederickson, C. J. (1989) Neurobiology of zinc and zinc-containing neurons, Int. Rev. Neurobiol. 31, 145-328.
43. Owen, C. A. (1982) Copper in the Nervous System, in Physiological Aspects of Copper, pp 160-191, Noyes Publications, Park Ridge, NJ.
44. Owen, C. A. (1982) Copper-Protein Binding: Copper Transport, in Biochemical Aspects of Copper, pp 177-186, Noyes Publications, Park Ridge, NJ.
45. Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains, J. Neurochem. 52, 515-520.
46. Warren, P. J., Earl, C. J., and Thompson, H. S. (1960) The distribution of copper in human brain, Brain 83, 709-717.
47. Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Tanzi, R. E., Masters, C. L., and Bush, A. I. (1999) Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion, J. Biol. Chem. 274, 23223-23228.
48. Yates, C. M., Butterworth, J., Tennant, M. C., and Gordon, A. (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementia, J. Neurochem. 55, 1624-1630.
49. Martins, R. N., Harper, C. G., Stokes, G. B., and Masters, C. L. (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J. Neurochem. 46, 1042-1045.
50. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., and Markesbery, W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 88, 10540-10543.
51. Smith, M. A., Richey, P. L., Taneda, S., Kutty, R. K., Sayre, L. M., Monnier, V. M., and Perry, G. (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease, Ann. N.Y. Acad. Sci. 738, 447-454.
52. Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stem, D., Sayre, L. M., Monnier, V. M., and Perry, G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. U.S.A. 91, 5710-5714.
53. Hensley, K., Hall, N., Subramanian, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., Lovell, M., Markesbery, W. R., and Butterfield, D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem. 65, 2146-2156.
54. Sayre, L. M., Perry, G., Harris, P. L., Liu, Y., Schubert, K. A., and Smith, M. A. (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals, J. Neurochem. 74, 270-279.
55. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Bamham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K. T., Zheng, H., Tanzi, R. E., Masters, C. L., and Bush, A. I. (2001) Treatment of a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer Disease Transgenic Mice, Neuron 30, 665-676.
56. Galeazzi, L., Ronchi, P., Franceschi, C., and Giunta, S. (1999) In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation, Amyloid 6, 7-13.
57. Rogers, J., Luber-Narod, J., Styren, S. D., and Civin, W. H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease, Neurobiol. Aging 9, 339-349.
58. McGeer, P. L., Akiyama, H., Itagaki, S., and McGeer, E. G. (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients, Neurosci. Lett. 107, 341-346.
59. Styren, S. D., Civin, W. H., and Rogers, J. (1990) Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain, Exp. Neurol. 10, 3-104.
60. Reynolds, W. F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R. A., and Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease, Exp. Neurol. 155, 31-41.
61. Atwood, C. S., Huang, X., Moir, R. D., Smith, M. A., Tanzi, R. E., Roher, A. E., Bush, A. I., and Perry, G. (2001) Neuroinflammatory Responses in the Alzheimer's Disease Brain Promote the Oxidative Post-translational Modification of Amyloid Deposits, in Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics (Iqbal, K., Sisodia, S. S., and Winblad, B., Eds.) pp 341-361, John Wiley & Sons, London.
62. Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., and Floyd, R. A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neurosci. 18, 8126-8132.
63. Basun, H., Forssell, L. G., Wetterberg, L., and Winblad, B. (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease, J. Neural Transm. 3, 231-258.